Message From Wall Street: Cap Those Price Increases
This article was originally published in RPM Report
Executive Summary
With the Democrats in control of Congress and high drug prices still making headlines, some Wall Street analysts are suggesting a proactive, and surprising, response from Big Pharma: voluntary price caps.